S. Pecorelli, L. Zigliani, and F. Odicino, Revised FIGO staging for carcinoma of the cervix, Int J Gynaecol Obstet, vol.105, pp.107-115, 2009.

H. J. Choi, W. Ju, S. K. Myung, and Y. Kim, Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: metaanalysis, Cancer Sci, vol.101, pp.1471-1480, 2010.

M. Resbeut, E. Fondrinier, B. Fervers, C. Haie-meder, A. Bataillard et al., Standards, options and recommendations for the management of invasive cervical cancer patients (non metastastic), Bull Cancer, vol.90, pp.333-379, 2003.

W. Park, Y. J. Park, S. J. Huh, B. G. Kim, D. S. Bae et al., The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer, Jpn J Clin Oncol, vol.35, pp.260-264, 2005.

Y. Lee, C. H. Choi, C. J. Kim, H. Kang, T. Kim et al., The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results, Gynecol Oncol, vol.115, pp.65-73, 2009.

J. Leseur, A. Devillers, D. Williaume, L. Prisé, E. Fougerou et al., 18F-fluorodeoxyglucose PET/CT in cervix cancer: lymph node assessment and prognostic/predictive value of primary tumour analysis, Cancer Radiother, vol.15, pp.699-708, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00739967

E. A. Kidd, B. A. Siegel, F. Dehdashti, and P. W. Grigsby, The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival, Cancer, vol.110, pp.1738-1782, 2007.

F. Xue, L. L. Lin, F. Dehdashti, T. R. Miller, B. A. Siegel et al., F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy, Gynecol Oncol, vol.101, pp.147-51, 2006.

, Prise en charge initiale des cancers gynécologiques : référentiels de la Société française d'oncologie gynécologique

P. G. Rose, L. P. Adler, M. Rodriguez, P. F. Faulhaber, F. W. Abdul-karim et al., Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study, J Clin Oncol, vol.17, pp.41-46, 1999.

A. Loft, A. K. Berthelsen, H. Roed, C. Ottosen, L. Lundvall et al., The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study, Gynecol Oncol, vol.106, pp.29-34, 2007.

T. Yen, L. See, C. Lai, C. W. Yah-huei, K. Ng et al., 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression, J Nucl Med, vol.45, pp.22-31, 2004.

S. I. Park, D. S. Suh, S. Kim, K. U. Choi, and M. Yoon, Correlation between biological marker expression and F-fluorodeoxyglucose uptake in cervical cancer measured by positron emission tomography, Onkologie, vol.36, pp.169-74, 2013.

C. Merlin, F. Cachin, A. Kelly, D. Mestas, D. Freitas et al., Prediction of lymph node status in uterine cervical cancer with 18FDG-PET/CT-value of primary tumor uptake, Med Nucl, vol.32, pp.313-66, 2008.

L. Pan, J. Cheng, M. Zhou, Z. Yao, and Y. Zhang, The SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) and serum squamous cell carcinoma antigen (SCC-ag) function as prognostic biomarkers in patients with primary cervical cancer, J Cancer Res Clin Oncol, vol.138, pp.239-285, 2012.

T. R. Miller and P. W. Grigsby, Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy, Int J Radiat Oncol Biol Phys, vol.53, pp.353-362, 2002.

E. A. Kidd, C. R. Spencer, P. C. Huettner, B. A. Siegel, F. Dehdashti et al., Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake, Cancer, vol.115, pp.3548-54, 2009.

X. C. Nguyen, W. W. Lee, J. Chung, S. Y. Park, S. W. Sung et al., FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-smallcell lung cancer: correlations and prognostic values, Eur J Radiol, vol.62, pp.214-223, 2007.

H. Kawana, J. Tamaru, T. Tanaka, A. Hirai, Y. Saito et al., Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of nonsmall cell lung cancer, Am J Pathol, vol.153, pp.505-518, 1998.

A. C. Buck, H. H. Schirrmeister, C. A. Guhlmann, C. G. Diederichs, C. Shen et al., Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity?, J Nucl Med, vol.42, pp.721-726, 2001.

P. Morice, D. Castaigne, P. Pautier, A. Rey, C. Haie-meder et al., Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma, Gynecol Oncol, vol.73, pp.106-116, 1999.

E. A. Kidd, B. A. Siegel, F. Dehdashti, J. S. Rader, D. G. Mutch et al., Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis, J Clin Oncol, vol.28, pp.2108-2121, 2010.

S. H. Kim, S. C. Kim, B. I. Choi, and M. C. Han, Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging, Radiology, vol.190, pp.807-818, 1994.

S. Houdebine, M. Ricaud-couprie, C. Labbe-devilliers, I. Doutriaux-dumoulin, D. Geffroy et al., Value of MRI for pelvic imaging: normal and pathological aspects, Med Nucl, vol.36, pp.451-459, 2012.

N. Morisawa, T. Koyama, and K. Togashi, Metastatic lymph nodes in urogenital cancers: contribution of imaging findings, Abdom Imaging, vol.31, pp.620-629, 2006.

M. M. Juretzka, K. C. Jensen, T. A. Longacre, N. N. Teng, and A. Husain, Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis, Gynecol Oncol, vol.93, pp.107-118, 2004.

J. Fregnani, M. Latorre, P. R. Novik, A. Lopes, and F. A. Soares, Assessment of pelvic lymph node micrometastatic disease in stages IB and IIA of carcinoma of the uterine cervix, Int J Gynecol Cancer, vol.16, pp.1188-94, 2006.

L. Horn, B. Hentschel, U. Fischer, D. Peter, and K. Bilek, Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: frequency, topographic distribution and prognostic impact, Gynecol Oncol, vol.111, pp.276-81, 2008.

S. Sironi, A. Buda, M. Picchio, P. Perego, R. Moreni et al., Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT, Radiology, vol.238, pp.272-281, 2006.

H. Chou, T. Chang, Y. Ng, K. Hsueh, S. Ma et al., Low value of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy, J Clin Oncol, vol.24, pp.123-131, 2006.

F. Lécuru, P. Mathevet, D. Querleu, E. Leblanc, P. Morice et al., Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study, J Clin Oncol, vol.29, pp.1686-91, 2011.

H. Lerman, U. Metser, D. Grisaru, A. Fishman, G. Lievshitz et al., Normal and abnormal 18F-FDG endometrial and ovarian uptake in preand postmenopausal patients: assessment by PET/CT, J Nucl Med, vol.45, pp.266-71, 2004.

C. Uzan, A. Souadka, S. Gouy, T. Debaere, J. Duclos et al., Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advancedstage cervical cancer and negative PET-CT imaging in the para-aortic area, Oncologist, vol.16, pp.1021-1028, 2011.

P. T. Ramirez and M. R. Milam, Laparoscopic extraperitoneal paraaortic lymphadenectomy in patients with locally advanced cervical cancer, Gynecol Oncol, vol.104, pp.9-12, 2007.

M. Boughanim, S. Leboulleux, A. Rey, C. T. Pham, Y. Zafrani et al., Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area, J Clin Oncol, vol.26, pp.2558-61, 2008.

Y. Yildirim, S. Sehirali, M. E. Avci, C. Yilmaz, K. Ertopcu et al., Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings, Gynecol Oncol, vol.108, pp.154-163, 2008.

W. C. Lin, Y. C. Hung, L. S. Yeh, C. H. Kao, R. F. Yen et al., Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings, Gynecol Oncol, vol.89, pp.73-79, 2003.

B. Zand, E. D. Euscher, P. T. Soliman, K. M. Schmeler, R. L. Coleman et al., Rate of para-aortic lymph node micrometastasis in patients with locally advanced cervical cancer, Gynecol Oncol, vol.119, pp.422-427, 2010.

A. Martínez, E. Mery, G. Ferron, and D. Querleu, Incidence of micrometastases in histologically negative para-aortic lymph nodes in advanced cervical cancer patients, Gynecol Oncol, vol.119, pp.76-80, 2010.